Company
Last deal
$16.M
Amount
Venture - Series Unknown
Stage
29.09.2011
Date
2
all rounds
$96.5M
Total amount
General
About Company
Proximagen is developing drugs for neurodegenerative disorders.
Industry
Sector :
Subsector :
Keywords :
founded date
01.01.2003
Number of employees
Company Type
For Profit
Last funding type
Venture - Series Unknown
IPO status
Private